Consumer Coalition logo

Please wait...

We're making sure an attorney is available for your potential claim.


Zantac® Linked to Multiple Forms of Cancer

NDMA, a cancer-causing substance, has been found at unsafe levels in the popular heartburn drug.

If you or a loved one developed cancer after taking Zantac®, you may be eligible for compensation.

Get your FREE claim review!

Our team of experts is standing by!

How may we contact you?

Please review the fields highlighted in red.

By clicking the “See If I Qualify” button, you agree to the Terms and Conditions and Privacy Policy and authorize Consumer Coalition and its marketing partners, affiliates, service providers, and clients to contact you by email or at the phone number you entered using automated technology including recurring auto-dialers, pre-recorded messages, and text messages, even if your phone is a mobile number or is currently listed on any state, federal, or corporate “Do Not Call” list. You understand that your telephone company may impose charges on you for these contacts, and that you can revoke this consent at any time. For SMS campaigns Text STOP to cancel and HELP for help. Message and data rates may apply. By clicking the “See If I Qualify” button and submitting this form, I affirm that I have read and agree to this Site’s Terms and Conditions (including the arbitration provision and the E-SIGN consent) and Privacy Policy.

The U.S. Food and Drug Administration (FDA) is requesting manufacturers to withdraw all Zantac® and generic, over-the-counter ranitidine drugs from the market, effective immediately.

The FDA determined that N-Nitrosodimethylamine (NDMA) levels in some ranitidine medications "increases over time, and when stored at higher than room temperatures, may result in consumer exposure to unacceptable levels."

The FDA, Environmental Protection Agency (EPA), and the World Health Organization (WHO) all classify NDMA as a cancer-causing substance.

Contact Consumer Coalition today for your free, confidential claim review.